ES540029A0 - Procedimiento para preparar aldehidos peptidos conteniendo prolina con actividad farmaceutica. - Google Patents

Procedimiento para preparar aldehidos peptidos conteniendo prolina con actividad farmaceutica.

Info

Publication number
ES540029A0
ES540029A0 ES540029A ES540029A ES540029A0 ES 540029 A0 ES540029 A0 ES 540029A0 ES 540029 A ES540029 A ES 540029A ES 540029 A ES540029 A ES 540029A ES 540029 A0 ES540029 A0 ES 540029A0
Authority
ES
Spain
Prior art keywords
procedure
pharmaceutical activity
peptide aldehydes
containing proline
aldehydes containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES540029A
Other languages
English (en)
Other versions
ES8705465A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838311423A external-priority patent/GB8311423D0/en
Priority claimed from GB838314708A external-priority patent/GB8314708D0/en
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Publication of ES540029A0 publication Critical patent/ES540029A0/es
Publication of ES8705465A1 publication Critical patent/ES8705465A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES540029A 1983-04-27 1985-01-31 Procedimiento para preparar aldehidos peptidos conteniendo prolina con actividad farmaceutica. Expired ES8705465A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838311423A GB8311423D0 (en) 1983-04-27 1983-04-27 Proline derivatives
GB838314708A GB8314708D0 (en) 1983-05-27 1983-05-27 Proline derivatives

Publications (2)

Publication Number Publication Date
ES540029A0 true ES540029A0 (es) 1987-05-01
ES8705465A1 ES8705465A1 (es) 1987-05-01

Family

ID=26285956

Family Applications (2)

Application Number Title Priority Date Filing Date
ES532007A Expired ES8701154A1 (es) 1983-04-27 1984-04-27 Procedimiento para preparar derivados de prolina.
ES540029A Expired ES8705465A1 (es) 1983-04-27 1985-01-31 Procedimiento para preparar aldehidos peptidos conteniendo prolina con actividad farmaceutica.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES532007A Expired ES8701154A1 (es) 1983-04-27 1984-04-27 Procedimiento para preparar derivados de prolina.

Country Status (15)

Country Link
US (2) US4596789A (es)
EP (1) EP0124317B1 (es)
AU (1) AU580955B2 (es)
CA (1) CA1253297A (es)
DE (1) DE3481913D1 (es)
DK (1) DK209784A (es)
ES (2) ES8701154A1 (es)
FI (1) FI841601A (es)
GR (1) GR81937B (es)
HU (1) HUT34041A (es)
IE (1) IE57350B1 (es)
IL (1) IL71614A0 (es)
NO (1) NO841665L (es)
NZ (1) NZ207965A (es)
PT (1) PT78502B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1267499A (en) * 1983-07-12 1990-04-03 Cedric H. Hassall Peptide amides and aldehydes
DD248961A1 (de) * 1984-05-22 1987-08-26 Akad Wissenschaften Ddr Verfahren zur herstellung wundheilungsfoerdernder praeparationen
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
GB8613704D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro keto compounds
DE3782191T2 (de) * 1986-06-05 1993-02-25 Ici America Inc Difluorketoverbindungen.
EP0248562B1 (en) * 1986-06-05 1995-10-25 Zeneca Inc. Difluoro peptide compounds
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
JPH075634B2 (ja) * 1987-10-30 1995-01-25 日東紡績株式会社 トリペプチド類及びこれを含有する抗プラスミン剤
FR2622581B1 (fr) * 1987-11-03 1990-02-16 Inorgan Sa Rech Develop Pharm Nouveaux derives de l-proline, leur preparation et leurs applications biologiques
US5736520A (en) * 1988-10-07 1998-04-07 Merrell Pharmaceuticals Inc. Peptidase inhibitors
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
CA2001629A1 (en) * 1988-10-27 1990-04-27 George A. Digenis Human leukocyte elastase inhibitors and methods of producing and using same
EP0490379A3 (de) * 1990-12-13 1992-06-24 BERLIN-CHEMIE Aktiengesellschaft Diaminosäurederivate und pharmazeutische Zusammensetzungen
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2700165B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
DE69637307T2 (de) * 1995-11-28 2008-02-28 Cephalon, Inc. Aus d-aminosäuren abgeleitete cystein-und serinproteasehemmer
CA2286722C (en) 1997-04-18 2010-10-19 Cephalon Inc. Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
DE69827956T2 (de) * 1997-08-11 2005-04-14 Boehringer Ingelheim (Canada) Ltd., Laval Peptidanaloga mit inhibitorischer wirkung auf hepatitis c
CN102372764A (zh) 2000-07-21 2012-03-14 先灵公司 用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
EP1476573B1 (en) 2002-01-28 2010-01-06 Ambion, Inc. Crude biological derivatives competent for nucleic acid detection
KR101115294B1 (ko) * 2003-05-21 2012-04-12 베링거 인겔하임 인터내셔날 게엠베하 Ｃ형 간염 억제제 화합물
JP4914355B2 (ja) * 2004-07-20 2012-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃ型肝炎インヒビターペプチド類似体
UY29016A1 (es) * 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
CL2007002166A1 (es) * 2006-07-24 2008-01-25 Tetralogic Pharm Corp Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer.
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
US20080319221A1 (en) * 2007-06-22 2008-12-25 Bernd Junker Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
DE102007054497B3 (de) * 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2010071833A1 (en) 2008-12-19 2010-06-24 Life Technologies Corporation Proteinase k inhibitors, methods and compositions therefor
WO2013004636A1 (en) * 2011-07-01 2013-01-10 Novozymes A/S Stabilized subtilisin composition
CN110799193B (zh) 2017-03-21 2023-12-12 斯克利普斯研究院 铜和镍催化的脱羧硼化反应
MX2021015894A (es) 2019-07-01 2022-02-03 Basf Se Peptidos acetales para estabilizar enzimas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE629254C (de) * 1934-06-28 1936-04-25 Fried Krupp Grusonwerk Akt Ges Vorrichtung zum Glaetten der Arbeitswalzen eines Walzwerks waehrend des Betriebes
US3867364A (en) * 1968-11-21 1975-02-18 Microbial Chem Res Found Process for the synthesis of leupeptins and their analogues
US3935280A (en) * 1975-01-10 1976-01-27 Aldrich-Boranes, Inc. Reduction of amino acids in the presence of boron trifluoride
CH629254A5 (en) * 1976-10-14 1982-04-15 Nippon Kayaku Kk Process for preparing L-leupeptins
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
CS226907B1 (en) * 1981-08-07 1984-04-16 Kasafirek Evzen Alkylamides of carboxyalkanoylpeptides
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
CA1267499A (en) * 1983-07-12 1990-04-03 Cedric H. Hassall Peptide amides and aldehydes

Also Published As

Publication number Publication date
DK209784D0 (da) 1984-04-26
EP0124317A3 (en) 1987-01-14
HUT34041A (en) 1985-01-28
GR81937B (es) 1984-12-12
IE57350B1 (en) 1992-08-12
PT78502A (en) 1984-05-01
CA1253297A (en) 1989-04-25
ES532007A0 (es) 1986-11-16
EP0124317B1 (en) 1990-04-11
ES8701154A1 (es) 1986-11-16
EP0124317A2 (en) 1984-11-07
FI841601A0 (fi) 1984-04-24
US4691007A (en) 1987-09-01
FI841601A (fi) 1984-10-28
AU2744484A (en) 1984-11-01
IE840985L (en) 1984-10-27
DK209784A (da) 1984-10-28
NO841665L (no) 1984-10-29
DE3481913D1 (de) 1990-05-17
AU580955B2 (en) 1989-02-09
NZ207965A (en) 1987-08-31
US4596789A (en) 1986-06-24
ES8705465A1 (es) 1987-05-01
PT78502B (en) 1986-07-22
IL71614A0 (en) 1984-07-31

Similar Documents

Publication Publication Date Title
ES540029A0 (es) Procedimiento para preparar aldehidos peptidos conteniendo prolina con actividad farmaceutica.
ES551113A0 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
ES530203A0 (es) Procedimiento para preparar 1h-azol-1-etanoles alfa, alfa-disustituidos
DK364683A (da) Sproejte, isaer til medicinsk anvendelse
ES516154A0 (es) Procedimiento para preparar polipeptidos.
NO163643C (no) Framgangsmaate for aa sammenfoeye flere materiallag.
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
MX161186A (es) Procedimiento para preparar peptidos
ES523733A0 (es) Procedimiento para preparar acilanilidas.
ES543973A0 (es) Procedimiento para preparar peptidos
IT1209659B (it) Perfezionamenti riguardanti la terapia con ciclosporine.
MX7572E (es) Procedimiento para preparar proteina unicelular
NO862439L (no) Farmasoeytiske preparater.
MX7655E (es) Procedimiento para preparar substancias proteinicas antitumorales
ES516549A0 (es) Procedimiento para preparar urea.
DE3875859T2 (de) Zubereitungen zur verbesserung der adcc-therapien.
ES522662A0 (es) Procedimiento para preparar piridil y quinolil-imidazolinonas.
AR231230A1 (es) Procedimiento para preparar preparados farmaceuticos basados en combinaciones de sulfonamida-potenciador
DE3381733D1 (de) Gelpraeparate zur externen applikation.
ES545868A0 (es) Procedimiento para preparar peptidos
IT1206323B (it) Preparazioni farmaceutiche con azione citostatica.
ES548569A0 (es) Procedimiento para preparar acidos corticosteroide-21-fosforicos.
ES540559A0 (es) Procedimiento para preparar diazepinoindoles.
ES514364A0 (es) Procedimiento para preparar 2-cianoesteroides.
DK166273C (da) Dialkanoyloxybenzyliden-dialkanoat, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende dette

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990405